Hi-Clearance Inc. (TPEX:1788)
128.00
+0.50 (0.39%)
Sep 24, 2026, 1:30 PM CST
Hi-Clearance Market Cap
Hi-Clearance has a market cap or net worth of 5.7 billion as of September 25, 2026. Its market cap has decreased by -7.58% in one year.
Market Cap
5.70B
Enterprise Value
6.40B
Revenue
4.41B
Ranking
n/a
PE Ratio
14.55
Stock Price
128.00
ChartMarket Cap Chart
Since October 18, 2004, Hi-Clearance's market cap has increased from 875.00M to 5.70B, an increase of 551.28%. That is a compound annual growth rate of 8.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 5.70B | -6.23% |
| Dec 31, 2025 | 6.08B | -2.15% |
| Dec 31, 2024 | 6.21B | 2.95% |
| Dec 29, 2023 | 6.03B | 3.39% |
| Dec 30, 2022 | 5.84B | -0.35% |
| Dec 30, 2021 | 5.86B | 30.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TaiDoc Technology | 13.41B |
| InnoCare Optoelectronics | 11.63B |
| United Orthopedic | 7.94B |
| Delta Asia International | 5.87B |
| WeLeader Biomedical | 3.36B |
| Apex Biotechnology | 3.03B |
| Bonraybio | 2.86B |
| Applied BioCode | 2.81B |